Sort
261,768 grants matching “gene therapy”
Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms
$2,103,231Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2022 · HG
Growth Factor Imaging
$2,103,186Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Using functional genomics to inform gene environment interactions for colorectal cancer
$2,103,158Ulrike Peters · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Biological role and pharmacology of EXPERA family proteins and their effect onsterol homeostasis
$2,102,917Assaf Alon · Yale University · R35 · FY2025 · GM
NOVEL THERAPEUTIC STRATEGIES IN LEUKEMIA AND LYMPHOMA
$2,102,745Dana-Farber Cancer Institute · P01 · FY2000 · CA
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
$2,102,471Kelan G Tantisira · University Of California, San Diego · R01 · FY2024 · HL
Biomedical Research Excellence in Molecular Targets
$2,102,273University Of Louisville · P20 · FY2004 · RR
Center of Biomedical Research Excellence in Molecular *
$2,102,173University Of Louisville · P20 · FY2005 · RR
IMMUNOLOGY AND MOLECULAR VIROLOGY OF ACUTE HIV INFECTION
$2,102,133Fred Hutchinson Cancer Research Center · U01 · FY2000 · AI
Developmental and HyperActive Ras Tumor SPORE
$2,102,055David W. Clapp · Indiana University Indianapolis · U54 · FY2018 · CA
Genetic Architecture of Alzheimerâs disease Proteinopathies
$2,101,955M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
$2,101,713Susan M Chang · University Of California, San Francisco · P01 · FY2014 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$2,101,526John E Wagner · University Of Minnesota · P01 · FY2023 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2021 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2020 · CA
Multiscale Analysis of Immune Responses
$2,101,312Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Understanding the Origins of Early COPD
$2,101,189Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,101,177Sallie R. Permar · Duke University · P01 · FY2019 · AI
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,100,780Joel Moss · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Dissecting the establishment and regulation of human pluripotency
$2,100,751Alexander Meissner · Harvard University · P01 · FY2019 · GM
Dissecting the establishment and regulation of human pluripotency
$2,100,751Alexander Meissner · Harvard University · P01 · FY2021 · GM
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
$2,100,640Brian E Henderson · University Of Southern California · P01 · FY2006 · CA
Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Cohort Study.â
$2,100,604Frank J Penedo · University Of Miami Coral Gables · UH3 · FY2025 · CA
Mechanisms and Markers of Prostate Cancer Metastases
$2,100,602University Of Washington · P01 · FY2003 · CA
ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA
$2,100,342Marek-Marsel M Mesulam · Northwestern University At Chicago · R01 · FY2024 · AG